Aetna Now Covered by Sterne Agee (AET)
Research analysts at Sterne Agee assumed coverage on shares of Aetna (NYSE:AET) in a report released on Friday, TheFlyOnTheWall.com reports. The firm set a “neutral” rating and a $87.00 price target on the stock. Sterne Agee’s target price points to a potential upside of 6.03% from the stock’s previous close.
The analysts wrote, “Aetna is executing supremely well in a challenging environment. However, we see less earnings power upside potential without acquisitions from here given current excellent execution. This isn’t the first time AET has been able to out-execute peers in a challenging commercial margin environment, as AET was also successful in 2008 during the last cycle downturn. The last time we saw significant margin pressures among the publicly traded health plans in 2008, AET was able to deliver 13% EPS growth, though the following year proved more challenging.”
Several other analysts have also recently commented on the stock. Analysts at Zacks reiterated a “neutral” rating on shares of Aetna in a research note on Thursday, June 19th. They now have a $85.00 price target on the stock. Separately, analysts at JPMorgan Chase & Co. reiterated an “overweight” rating on shares of Aetna in a research note on Wednesday, June 18th. They now have a $82.00 price target on the stock, up previously from $81.00. Finally, analysts at JPMorgan Chase & Co. reiterated an “overweight” rating on shares of Aetna in a research note on Tuesday, June 3rd. They now have a $81.00 price target on the stock, up previously from $78.00. Six analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. Aetna currently has an average rating of “Buy” and a consensus target price of $81.06.
In other Aetna news, Director Molly Joel Coye sold 1,650 shares of Aetna stock in a transaction dated Monday, June 16th. The shares were sold at an average price of $80.60, for a total transaction of $132,990.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.
Shares of Aetna (NYSE:AET) traded down 0.74% on Friday, hitting $81.44. 300,250 shares of the company’s stock traded hands. Aetna has a 52-week low of $60.32 and a 52-week high of $82.49. The stock’s 50-day moving average is $78.29 and its 200-day moving average is $72.41. The company has a market cap of $29.107 billion and a price-to-earnings ratio of 14.44.
Aetna (NYSE:AET) last issued its quarterly earnings data on Thursday, April 24th. The company reported $1.98 earnings per share for the quarter, beating the analysts’ consensus estimate of $1.55 by $0.43. The company had revenue of $13.97 billion for the quarter, compared to the consensus estimate of $13.69 billion. During the same quarter last year, the company posted $1.50 earnings per share. Aetna’s revenue was up 46.9% compared to the same quarter last year. On average, analysts predict that Aetna will post $6.53 earnings per share for the current fiscal year.
The company also recently announced a quarterly dividend, which is scheduled for Friday, July 25th. Investors of record on Thursday, July 10th will be paid a dividend of $0.225 per share. This represents a $0.90 annualized dividend and a dividend yield of 1.10%. The ex-dividend date is Tuesday, July 8th.
Aetna Inc (NYSE:AET), is a diversified healthcare benefits company.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.